<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>M Zhang on Raunak Shrestha</title>
    <link>/authors/m-zhang/</link>
    <description>Recent content in M Zhang on Raunak Shrestha</description>
    <generator>Source Themes academia (https://sourcethemes.com/academic/)</generator>
    <language>en-us</language>
    <copyright>Copyright &amp;copy; {year} Raunak Shrestha</copyright>
    <lastBuildDate>Mon, 28 Jul 2025 00:00:00 +0000</lastBuildDate>
    
	    <atom:link href="/authors/m-zhang/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Genome-scale CRISPR screens identify PTGES3 as a direct modulator of AR function in advanced prostate cancer</title>
      <link>/publication/2025_ptges3/</link>
      <pubDate>Mon, 28 Jul 2025 00:00:00 +0000</pubDate>
      
      <guid>/publication/2025_ptges3/</guid>
      <description></description>
    </item>
    
    <item>
      <title>An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression</title>
      <link>/publication/2024_wcdt_atacseq/</link>
      <pubDate>Thu, 11 Jul 2024 00:00:00 +0000</pubDate>
      
      <guid>/publication/2024_wcdt_atacseq/</guid>
      <description>&lt;blockquote class=&#34;twitter-tweet&#34;&gt;&lt;p lang=&#34;en&#34; dir=&#34;ltr&#34;&gt;Thrilled! Our study &amp;quot;An Atlas of Accessible Chromatin in Advanced Prostate Cancer..&amp;quot; is now online &lt;a href=&#34;https://twitter.com/CR_AACR?ref_src=twsrc%5Etfw&#34;&gt;@CR_AACR&lt;/a&gt;&lt;br&gt;Thank you &lt;a href=&#34;https://twitter.com/felixfengmd?ref_src=twsrc%5Etfw&#34;&gt;@felixfengmd&lt;/a&gt; &lt;a href=&#34;https://twitter.com/David_A_Quigley?ref_src=twsrc%5Etfw&#34;&gt;@David_A_Quigley&lt;/a&gt; &lt;a href=&#34;https://twitter.com/MatLupien?ref_src=twsrc%5Etfw&#34;&gt;@MatLupien&lt;/a&gt; for amazing mentorship &amp;amp; &lt;a href=&#34;https://twitter.com/PCF_Science?ref_src=twsrc%5Etfw&#34;&gt;@PCF_science&lt;/a&gt;, the Benioff Institute, &lt;a href=&#34;https://twitter.com/UCSFCancer?ref_src=twsrc%5Etfw&#34;&gt;@UCSFCancer&lt;/a&gt; for their support! &lt;a href=&#34;https://t.co/O2zTlzCsqh&#34;&gt;https://t.co/O2zTlzCsqh&lt;/a&gt;&lt;/p&gt;&amp;mdash; Raunak Shrestha, PhD (@raunakms) &lt;a href=&#34;https://twitter.com/raunakms/status/1811506881405550716?ref_src=twsrc%5Etfw&#34;&gt;July 11, 2024&lt;/a&gt;&lt;/blockquote&gt; &lt;script async src=&#34;https://platform.twitter.com/widgets.js&#34; charset=&#34;utf-8&#34;&gt;&lt;/script&gt;</description>
    </item>
    
    <item>
      <title>Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer</title>
      <link>/publication/2024_wcdt_hic/</link>
      <pubDate>Sun, 09 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>/publication/2024_wcdt_hic/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression</title>
      <link>/publication/2024_alternative_promoter/</link>
      <pubDate>Sun, 09 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>/publication/2024_alternative_promoter/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The genomic and epigenomic landscape of double-negative metastatic prostate cancer</title>
      <link>/publication/2023_dnpc/</link>
      <pubDate>Thu, 08 Jun 2023 00:00:00 +0000</pubDate>
      
      <guid>/publication/2023_dnpc/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The 5-Hydroxymethylcytosine Landscape of Prostate Cancer</title>
      <link>/publication/2022_prostate5hmc/</link>
      <pubDate>Wed, 02 Nov 2022 00:00:00 +0000</pubDate>
      
      <guid>/publication/2022_prostate5hmc/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Predicting Cancer Drug TARGETS - TreAtment Response GlmnET Signatures</title>
      <link>/publication/2021_target/</link>
      <pubDate>Tue, 21 Sep 2021 00:00:00 +0000</pubDate>
      
      <guid>/publication/2021_target/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Autoantibody landscape in patients with advanced prostate cancer</title>
      <link>/publication/2020_prostateab/</link>
      <pubDate>Wed, 23 Sep 2020 00:00:00 +0000</pubDate>
      
      <guid>/publication/2020_prostateab/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
